Evidence map›Paper›PMID 32863886›Full record

ArticleBioData mining2020

Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease.

Qichao Hu, Shizhang Wei, Jianxia Wen, Wenwen Zhang, Yinxiao Jiang, Caiyan Qu, Junbao Xiang, Yanling Zhao, Xi Peng, Xiao Ma

Open access · goldAbstract read
In one paragraph

Article in BioData mining, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qichao HuSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.ORCID 0000-0002-1646-3347
Shizhang WeiSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Jianxia WenSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Wenwen ZhangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Yinxiao JiangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Caiyan QuSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Junbao XiangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Yanling ZhaoDepartment of Pharmacy, Fifth Medical Center of PLA General Hospital, Beijing, 100039 China.
Xi PengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Xiao MaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137 China.
Chengdu University of Traditional Chinese Medicine · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-alcoholic fatty liver (NAFLD) is a chronic disease worldwide, which poses a huge threat to human health. Xiaochaihu decoction is a well-known traditional Chinese medicine prescription. It has been proven effective in treating NAFLD but its mechanism is still unclear.

objectiveMultiple mechanisms of Xiaochaihu decoction are explored by identifying and connecting potential targets and active ingredients in the treatment of NAFLD.

methodsActive ingredients and related targets of seven herbs were collected from TCMSP database. The related targets of NAFLD were obtained from Genes cards database, TDD and OMIM database. The intersected targets of disease targets and drug targets were input into STRING database to construct protein-protein interaction network. DAVID database was used for GO enrichment analysis and KEGG enrichment analysis.

resultsAfter screening and removal of duplicates, a total of 145 active ingredients and 105 potential targets were obtained. PPI network manifested that AKT1, IL6, JUN MAPK8 and STAT3 were the key target proteins. The results of GO enrichment analysis mainly involved cytokine receptor binding, cytokine activity, and heme binding. The results of KEGG analysis suggested that the mechanism mainly involved in AGE-RAGE signaling pathway in diabetic complications, Hepatitis C, fluid shear stress and atherosclerosis. The signaling pathways were further integrated as network manner, including AGE-RAGE signaling pathway in diabetic complications, Fluid shear stress and atherosclerosis, Insulin resistance, HIF-1 signaling pathway, Th17 cell differentiation and IL-17 signaling pathway. The network contained immunity regulation, metabolism regulation and oxidative stress regulation.

conclusionXiaochaihu decoction plays a key role in the treatment of NAFLD with multiple targets and pathways. Immunity regulation, metabolism regulation and oxidative stress regulation consist of the crucial regulation cores in mechanism. GRAPHICAL ABSTRACT: Design and workflow of this study.

Indexed as

Immunity regulationMetabolism regulationNAFLDNetwork pharmacologyOxidative stress regulationXiaochaihu decoction

Identifiers

PMID32863886
PMCPMC7450930
OpenAlexW3081679786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.